OR10V1

Across TCGA pan-cancer cohorts, OR10V1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated OR10V1 data layer compared with 15 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR10V1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR10V1 expression acts as an unfavorable survival marker.

COAD and LUSC are the cancer types where OR10V1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.159	0.799	.009	24	view →
LUSC	DFS	Median	All	0.144	0.797	<.001	8	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

OR10V1–COAD (OS)

Open the COAD breakdown →